TMCI
TMCI
NASDAQ · Health Care

Treace Medical Concepts Inc

$3.98
-0.29 (-6.79%)
As of Jun 30, 10:30 PM ET ·
Financial Highlights (FY 2026)
Revenue
218.08M
Net Income
-60,500,536
Gross Margin
79.8%
Profit Margin
-27.7%
Rev Growth
+14.5%
D/E Ratio
0.64
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 79.8% 79.8% 54.2% 54.2%
Operating Margin -26.7% -24.1% 18.2% 18.5%
Profit Margin -27.7% -26.4% 13.5% 12.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 218.08M 190.52M 42.92M 46.18M
Gross Profit 174.05M 152.05M 23.26M 25.03M
Operating Income -58,337,331 -45,866,688 7.80M 8.54M
Net Income -60,500,536 -47,567,469 5.79M 5.86M
Gross Margin 79.8% 79.8% 54.2% 54.2%
Operating Margin -26.7% -24.1% 18.2% 18.5%
Profit Margin -27.7% -26.4% 13.5% 12.7%
Rev Growth +14.5% +14.5% +24.4% -6.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 56.27M 56.27M 8.48M 7.21M
Total Equity 88.40M 88.40M 83.95M 82.42M
D/E Ratio 0.64 0.64 0.10 0.09
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -47,441,606 -39,372,347 10.44M 11.89M
Free Cash Flow 4.81M 4.94M